Summary
University of Washington (UoW) is an educational institution that provides undergraduate, postgraduate and master’s degrees. The university offers courses in the areas of accounting, aeronautics, applied mathematics, bioengineering, business, social sciences, science, law, medicine, and public affairs. It also provides services in nursing, health services, astronomy, computer science, molecular biotechnology, and oceanography among others. UoW operates through its institutions such as College of Engineering, School of Dentistry, College of Architecture and Urban Planning, School of Pharmacy, School of Public Health and Community Medicine, School of Nursing, and School of Medicine, among others. UoW is headquartered in Seattle, Washington, the US.
University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
University of Washington, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Washington, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
University of Washington, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Washington, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
University of Washington, Medical Devices Deals, 2010 to YTD 2016 10
University of Washington, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
University of Washington, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Nexgenia Raises USD0.5 Million in Seed Financing Round 14
Partnerships 15
C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 15
Turing Pharma Enters into Partnership with Washington University 16
LEO Pharma Enters into Agreement with Washington University School of Medicine 17
Juno Therapeutics and Fred Hutchinson Cancer Research Center Enter into Joint Venture 18
Novo Nordisk Enters into Research Agreement with UW Medicine 19
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 20
GenVec Enters into Agreement with Washington University at St. Louis 21
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 22
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 23
OncoSec Medical Enters into Research Agreement with University of Washington 24
Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis 25
Horizon Discovery Enters Into Co-Development Agreement With University Of Washington 26
Fred Hutchinson Cancer Research Enters Into An Agreement With University of Washington 27
Pfizer Enters Into Collaboration With Washington University 28
Merger 30
Northwest Hospital Merges With UW Medicine 30
Licensing Agreements 31
Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 31
Optikira Enters into Licensing Agreement with University of California, San Francisco and University of Washington 32
Avalanche Biotech Enters into Licensing Agreement with University of Washington 33
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 34
GenetikSignal Enters Into Licensing Agreement With University Of Washington 35
Stella Therapeutics Enters into Licensing Agreement with University of Washington 36
Stella Therapeutics Enters into Licensing Agreement with University of Washington and University of Montana 37
ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside 38
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 40
Nexgenia Enters into Licensing Agreement with University of Washington 41
Resolve Therapeutics Enters Into Licensing Agreement With University of Washington 42
AttoDx Enters Into Licensing Agreement With University Of Washington And Seattle BioMed 43
Genocea Enters Into Licensing Agreement With University of Washington And Fred Hutchinson Cancer Research Center 44
University of Washington - Key Competitors 45
Key Employees 46
Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
University of Washington, Pharmaceuticals & Healthcare, Key Facts 1
University of Washington, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Washington, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
University of Washington, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Washington, Deals By Therapy Area, 2010 to YTD 2016 9
University of Washington, Medical Devices Deals, 2010 to YTD 2016 10
University of Washington, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Nexgenia Raises USD0.5 Million in Seed Financing Round 14
C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 15
Turing Pharma Enters into Partnership with Washington University 16
LEO Pharma Enters into Agreement with Washington University School of Medicine 17
Juno Therapeutics and Fred Hutchinson Cancer Research Center Enter into Joint Venture 18
Novo Nordisk Enters into Research Agreement with UW Medicine 19
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 20
GenVec Enters into Agreement with Washington University at St. Louis 21
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 22
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 23
OncoSec Medical Enters into Research Agreement with University of Washington 24
Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis 25
Horizon Discovery Enters Into Co-Development Agreement With University Of Washington 26
Fred Hutchinson Cancer Research Enters Into An Agreement With University of Washington 27
Pfizer Enters Into Collaboration With Washington University 28
Northwest Hospital Merges With UW Medicine 30
Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 31
Optikira Enters into Licensing Agreement with University of California, San Francisco and University of Washington 32
Avalanche Biotech Enters into Licensing Agreement with University of Washington 33
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 34
GenetikSignal Enters Into Licensing Agreement With University Of Washington 35
Stella Therapeutics Enters into Licensing Agreement with University of Washington 36
Stella Therapeutics Enters into Licensing Agreement with University of Washington and University of Montana 37
ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside 38
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 40
Nexgenia Enters into Licensing Agreement with University of Washington 41
Resolve Therapeutics Enters Into Licensing Agreement With University of Washington 42
AttoDx Enters Into Licensing Agreement With University Of Washington And Seattle BioMed 43
Genocea Enters Into Licensing Agreement With University of Washington And Fred Hutchinson Cancer Research Center 44
University of Washington, Key Competitors 45
University of Washington, Key Employees 46
University of Washington, Subsidiaries 47
List of Figures
University of Washington, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Washington, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Washington, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Washington, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Washington, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Washington, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
University of Washington, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Washington, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
University of Washington, Medical Devices Deals, 2010 to YTD 2016 10
